Article Dans Une Revue The Lancet Année : 2024

How effective is transcranial direct current stimulation?

Résumé

Gerrit Burkhardt and colleagues reported that the use of transcranial direct current stimulation (tDCS) as an additional treatment to stable selective serotonin reuptake inhibitor pharmacotherapy did not elicit further antidepressant effects in patients with major depressive disorder (MDD) [...].

DOI

Cite 10.1016/S0140-6736(23)00640-2 Autre Burkhardt, G., Kumpf, U., Crispin, A., Goerigk, S., Andre, E., Plewnia, C., Brendel, B., Fallgatter, A., Langguth, B., Abdelnaim, M., Hebel, T., Normann, C., Frase, L., Zwanzger, P., Diemer, J., Kammer, T., Schönfeldt-Lecuona, C., Kamp, D., Bajbouj, M., … Padberg, F. (2023). Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial. The Lancet, 402(10401), 545–554. https://doi.org/10.1016/s0140-6736(23)00640-2

Dates et versions

hal-04631121 , version 1 (01-07-2024)

Identifiants

Citer

Stéphane Perrey. How effective is transcranial direct current stimulation?. The Lancet, 2024, 403 (10445), pp.2688-2689. ⟨10.1016/S0140-6736(24)00634-2⟩. ⟨hal-04631121⟩
78 Consultations
0 Téléchargements

Altmetric

Partager

  • More